Literature DB >> 1982476

Selective opening of the blood-tumour barrier by intracarotid infusion of leukotriene C4.

K L Black1, W A King, K Ikezaki.   

Abstract

Intracarotid infusions of leukotriene C4 (LTC4) were used to selectively open the blood-tumour barrier in rats with RG-2 gliomas. Blood-brain and blood-tumour barrier permeability was determined by quantitative autoradiography using 14C aminoisobutyric acid. LTC4 (4 micrograms total dose) infused into the carotid artery ipsilateral to the tumour increased the unidirectional transfer constant for permeability, Ki, two-fold within the tumour while no effect on permeability was seen in the normal brain. No gamma glutamyl transpeptidase (gamma-GTP) activity was seen in tumour capillaries in contrast to high gamma-GTP in normal brain capillaries. These findings suggest that normal brain capillaries may resist the vasogenic effects of LTC4 while LTC4 will increase permeability in tumour capillaries. This could relate to the ability of gamma-GTP to act as an enzymatic barrier and inactivate leukotrienes in normal brain capillaries. Intracarotid LTC4 infusion may be a useful tool to selectively open the blood-tumour barrier for delivery of antineoplastic compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982476     DOI: 10.1007/978-3-7091-9115-6_47

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  2 in total

1.  Selective transvascular delivery of oligodeoxynucleotides to experimental brain tumors.

Authors:  H Koga; T Inamura; K Ikezaki; K Samoto; K Matsukado; M Fukui
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

2.  Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.

Authors:  Keith L Black; Dali Yin; Bindu M Konda; Xiao Wang; Jinwei Hu; MinHee K Ko; Jennifer-Ann Bayan; Manuel R Sacapano; Andres J Espinoza; John M Ong; Dwain Irvin; Yan Shu
Journal:  Brain Res       Date:  2008-06-21       Impact factor: 3.252

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.